Skip to main content

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Anna Penalba Morenilla

Institutions of which they are part

Main researcher
Neurovascular Diseases
Vall Hebron Institut de Recerca

Projects

Grup de Recerca en Malalties Neurovasculars

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Anna Rosell Novel, Manuel Quintana Luque
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 46800
Reference: 2009 SGR 432
Duration: 01/01/2010 - 30/04/2014

Identificación y uso de biomarcadores pronósticos en el ictus isquémico

IP: Joan Montaner Villalonga
Collaborators: Raquel Arias Gonzalez, Anna Penalba Morenilla, Olga Maisterra Santos
Funding agency: Instituto de Salud Carlos III
Funding: 228690
Reference: PI080361
Duration: 01/01/2009 - 31/12/2011

Estrategias para mejorar la eficacia y seguridad del tratamiento con Simvastatina en la Fase Aguda del Ictus Isquémico: STARS trial

IP: Joan Montaner Villalonga
Collaborators: Marta Aurora Rubiera Del Fueyo, José Alvarez Sabin, Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Olga Maisterra Santos, Marc Ribó Jacobi, Maria Pilar Delgado Martínez, Carlos Molina Cateriano, Estevo Santamarina Pérez
Funding agency: Instituto de Salud Carlos III
Funding: 175450
Reference: EC07/90195
Duration: 01/11/2007 - 30/06/2012

Estudio sobre las causas que originan diferencias de género en la enfermedad neurovascular ¿Es el Ictus una patología machista?

IP: Joan Montaner Villalonga
Collaborators: Anna Penalba Morenilla, Maria Mar Hernandez Guillamon, Maria Pilar Delgado Martínez
Funding agency: Instituto de Salud Carlos III
Funding: 41910
Reference: MD07/00209
Duration: 01/01/2008 - 31/05/2009

Related news

The TOUCH MSCA-COFUND doctoral training programme, led by UAB and focusing on the field of mental health, has opened its first call for applications, offering 13 doctoral positions.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Related professionals

Alfonso Biarnes Suñe

Alfonso Biarnes Suñe

Reconstructive Surgery of the Locomotor System
Read more
Laura Rodriguez Garcia

Laura Rodriguez Garcia

Read more
Mónica De Chiara Martí

Mónica De Chiara Martí

Read more
Anna Server Salvà

Anna Server Salvà

Main researcher
Musculoskeletal Tissue Engineering
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.